Literature DB >> 17033259

Hormonal control of inhibin B in men.

V A Giagulli1, D Carbone.   

Abstract

Serum inhibin B (IB) and testosterone (T) levels, secreted by Sertoli cells (SC) and Leydig cells (LC), respectively, are parameters of the functional state of these cells. Whereas LC activity and, consequently, T secretion are regulated by serum LH, factors regulating IB secretion by SC are still partially unknown. There is evidence that under certain conditions such as puberty, aging or some spermatogenesis defects, LH levels or Gn-independent factors might contribute to regulating SC activity and IB secretion. Among these factors, GH and IGF-I as well as PRL might have a role. Therefore, in order to explore the possible effects of either LH alone and FSH alone or a combination of both Gn, respectively, on SC function, IB plasma levels and spermatogenesis, we studied their effects in 6 patients with hypogonadotropic hypogonadism (HH), whereas the effects of GH on these parameters were studied in 6 men with panhypopituitarism (PH). Finally, the possible effects of PRL on SC function and spermatogenesis were studied in 6 patients with hyperprolactinemia (HPRL); 24 normal, fertile adults served as control group. In men with HH, neither human chorionic Gn (hCG) nor FSH, respectively, were able to increase serum IB after 3 months of therapy, whereas combined Gn therapy for 24 months increased IB plasma levels and stimulated spermatogenesis in 4 out of 6 hypogonadal men. In panhypopituitaric men, GH added to the classical Gn therapy did not have an additional effect on serum IB levels or spermatogenesis. Surprisingly, in our hyperprolactemic men, IB plasma levels were increased and positively correlated (p<0.01) with serum PRL levels, whereas normalization of the latter by cabergoline treatment caused a decrease of IB levels and a moderate increase in T, LH and FSH. In conclusion, the lack of SC response to FSH therapy alone, as opposed to the response to combined Gn therapy, might indicate that normalization of serum T by hCG is required to obtain IB secretion by SC. Addition of GH did not affect SC function, serum IB levels or spermatogenesis. Finally, our data suggest that PRL plasma levels might have a direct role on IB secretion, suggesting that the hypogonadism found in patients with HPRL might be a consequence of both central (inhibition of Gn secretion) and peripheral (stimulation of IB secretion) origin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17033259     DOI: 10.1007/BF03344180

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  52 in total

1.  Qualitative and quantitative decline in spermatogenesis of the follicle-stimulating hormone receptor knockout (FORKO) mouse.

Authors:  H Krishnamurthy; N Danilovich; C R Morales; M R Sairam
Journal:  Biol Reprod       Date:  2000-05       Impact factor: 4.285

2.  Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications.

Authors:  R I McLachlan; D M Finkel; W J Bremner; P J Snyder
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

3.  Maintenance of spermatogenesis induced by HMG treatment by means of continuous HCG treatment in hypogonadotrophic men.

Authors:  S G Johnsen
Journal:  Acta Endocrinol (Copenh)       Date:  1978-12

4.  Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction.

Authors:  B D Anawalt; R A Bebb; A M Matsumoto; N P Groome; P J Illingworth; A S McNeilly; W J Bremner
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

5.  Is inhibin B a pharmacodynamic parameter for FSH in normal men?

Authors:  A Kamischke; M Simoni; K Schrameyer; A Lerchl; E Nieschlag
Journal:  Eur J Endocrinol       Date:  2001-06       Impact factor: 6.664

Review 6.  Clinical review 96: Differential control of gonadotropin secretion in the human: endocrine role of inhibin.

Authors:  F J Hayes; J E Hall; P A Boepple; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

7.  Inhibin B secretion in males with gonadotropin-releasing hormone (GnRH) deficiency before and during long-term GnRH replacement: relationship to spontaneous puberty, testicular volume, and prior treatment--a clinical research center study.

Authors:  L B Nachtigall; P A Boepple; S B Seminara; R H Khoury; P M Sluss; A E Lecain; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

8.  Involvement of catecholamines and glutamate in GABAergic mechanism regulatory to luteinizing hormone and prolactin secretion.

Authors:  E Fuchs; T Mansky; K W Stock; E Vijayan; W Wuttke
Journal:  Neuroendocrinology       Date:  1984-06       Impact factor: 4.914

9.  Recovery of fertility in a hypogonadotropic man apparently resistant to gonadotrophin treatment.

Authors:  G Abbaticchio; F M Micale; V A Giagulli; R Giorgino
Journal:  Arch Androl       Date:  1985

10.  Growth hormone releasing hormone test for infertile men with spermatogenetic maturation arrest.

Authors:  Masato Fujisawa; Kunito Yamanaka; Hiroshi Okada; Soichi Arakawa; Sadao Kamidono
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

View more
  5 in total

Review 1.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

2.  Testosterone responses to standardized short-term sub-maximal and maximal endurance exercises: issues on the dynamic adaptive role of the hypothalamic-pituitary-testicular axis.

Authors:  P Sgrò; F Romanelli; F Felici; M Sansone; S Bianchini; C F Buzzachera; C Baldari; L Guidetti; F Pigozzi; A Lenzi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

3.  Circulating estradiol in men is inversely related to urinary metabolites of nonpersistent insecticides.

Authors:  John D Meeker; Sarena R Ravi; Dana B Barr; Russ Hauser
Journal:  Reprod Toxicol       Date:  2007-12-28       Impact factor: 3.143

4.  Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?

Authors:  V A Giagulli; M D Carbone; G De Pergola; E Guastamacchia; F Resta; B Licchelli; C Sabbà; V Triggiani
Journal:  J Assist Reprod Genet       Date:  2014-04-02       Impact factor: 3.412

5.  Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment.

Authors:  Karolina Bogefors; Yvonne Lundberg Giwercman; Jakob Eberhard; Olof Stahl; Eva Cavallin-Stahl; Gabriella Cohn-Cedermark; Stefan Arver; Aleksander Giwercman
Journal:  Asian J Androl       Date:  2017 Sep-Oct       Impact factor: 3.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.